RecruitingPhase 3NCT06810505
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Sponsor: AbbVie
Huntsville, AL · +31 more sites
Migraine clinical trials in Huntsville, AL
4 recruiting migraine studies with a site in Huntsville, AL.
RecruitingPhase 3NCT05711394
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Sponsor: AbbVie
Huntsville, AL · Saraland, AL · +40 more sites
RecruitingPhase 3NCT05125302
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Sponsor: AbbVie
Huntsville, AL · Saraland, AL · +123 more sites
RecruitingPhase 2NCT06602479
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
Sponsor: AbbVie
Birmingham, AL · Huntsville, AL · +14 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.